Daniel Nelson
@dwnelsonhpb
Surgical Oncologist | U.S. Army Veteran | Contributor @BehindTheKnife | California Dreamin’ ☀️ 🌊 🏄♂️
ID: 1460561179
https://www.researchgate.net/profile/Daniel_Nelson7 26-05-2013 20:11:36
1,1K Tweet
1,1K Takipçi
470 Takip Edilen
The yield of staging laparoscopy for resectable and borderline resectable pancreatic cancer in the #PREOPANC RCT Bas Groot Koerkamp Marc Besselink European Society of Surgical Oncology (ESSO) E-AHPBA YOUPPIE Pancreas RadOnc Tables DPCG Syed A. Ahmad Lee M. Ocuin MD, FACS Julie Hallet bit.ly/43bnerS
Raja Narayan, MD MPH Annals of Surgical Oncology Syed A. Ahmad Laleh Melstrom Jin He Syed Nabeel Zafar Zhi Ven Fong, MD MPH DrPH Woo Jin Choi MD PhD FRCSC Find the answer to this 🙋🏽♂️ ❓ and many more about cancer surgery 🦀 ✂️ 🔪 🪡 American College of Surgeons ACS Cancer Programs Operative Standards Volume 3 including Hepatobiliary. Available at your favorite bookstore 📕 or Kindle 🖥️ #CSSP #CRP
Achieving measurable quality metric standards improves outcomes in #PDAC Grateful to Annals of Surgical Oncology for the opportunity to share our work. Access our recent 📰 from Holly and team 👇 rdcu.be/deMcz Lexy Adams MD, MPH Elizabeth Barbera, MD Timothy Vreeland, MD Ching-Wei D. Tzeng @mkatzmd
Failure to receive both standard-adherent surgery and guideline-recommended treatments was independently associated with a 78% increased risk of death (HR 1.78; CI 1.70-1.86; p<0.001). Annals of Surgical Oncology Kelly McMasters, MD, PhD
INTRODUCING: Surgical Oncology Oral Board Audio Review. 46 high-yield scenarios covering all SCORE CGSO topics. Listen to full scenario 👇🏼 behindtheknife.teachable.com/p/btk-surgical… By surgical oncologists, for surgical oncologists! Jason Bingham Daniel Nelson Michael Yeh James Wu Michael David Alvarado
Who needs hypertrophy? When?PVE or LVD? Great talk by Jean-Nicolas Vauthey MD -Studies w/PVE vs LVD had insufficient PVE! (Low KGR) -sFLR<19% consider LVD -Y90 evaluated as option for contralateral hypertrophy while “treating” ipsilateral dz Ching-Wei D. Tzeng Hop S. Tran Cao SSAT #EWALT2023
🔥💯 masterclass on future surgical perspectives for pts w/iCCA from Hop S. Tran Cao at #EWALT2023 Inspiring leader in the fight against #cholangiocarcinoma MD Anderson Cancer Center Jean-Nicolas Vauthey MD CCA DIGEST Milind Javle Cholangiocarcinoma Foundation Ching-Wei D. Tzeng #oncsurgery
Expert lecture by Timothy Newhook on ctDNA-driven clinical decision-making for colorectal liver mets. Full auditorium at EWALT2023.de in Mainz. MD Anderson Cancer Center #oncsurgery AHPBA IHPBA SSAT Japanese Society of HBP Surgery Society of Surgical Oncology E-AHPBA
Jason Bingham Daniel Nelson and the rest of the crew hit it out of the park with these scenarios.
The #Surgery community lost a GREAT one today. Dr. Eric Johnson - surgeon, friend, soldier, combat veteran, husband, father, skydiver, base jumper, leader, educator, and so much more. RIP my friend, I miss you already. Keep on "slingin that hash"! American College of Surgeons
Thank you Annals of Surgical Oncology for highlighting our research #CSSP ACS Cancer Programs
Congrats to all the newly certified American Board of Surgery Society of Surgical Oncology Complex General Surgical Oncologists out there!!!
🩺🩺#ECGPulseCheck 🔎🔎 Should pts w/resectable high-risk iCCA (>5cm, node+, CA19-9, vascular invasion) be offered neoadjuvant therapy? Julie Hallet Cholangiocarcinoma Foundation Annals of Surgical Oncology Hop S. Tran Cao Flavio G Rocha, MD, FACS, FSSO Shishir K. Maithel Syed A. Ahmad Jean-Nicolas Vauthey MD Bas Groot Koerkamp Sean Cleary Milind Javle
🚨 NEW EPISODE ALERT 🚨 Whatcha know about circulating tumor DNA? Take a listen and get educated! Join MD Anderson Cancer Center Anish Jay Jain MD Timothy Newhook Jean-Nicolas Vauthey MD for a robust discussion. 🎧 app.behindtheknife.org/podcast/journa… 🎧
Looking for some easy listening on your Sunday? Check out our last 3 episodes: ✔️ Journal Review in Bariatric Surgery: Are Less Anastomoses Better? Matthew Martin, MD, FACS, McRIB Adrian Dan Crystal Johnson-Mann, MD, MPH, FACS, FASMBS ✔️ Are we failing our patients? Ventral hernia recurrence with B Todd Heniford Michael Rosen ✔️
Surgical Oncology Oral Boards are right around the corner. Check out this example scenario, which covers ADRENAL MASSES: 🎧app.behindtheknife.org/podcast/btk-su…🎧 Surg Onc Oral Board Audio Review: app.behindtheknife.org/premium/surgic… Daniel Nelson Jason Bingham
October Issue: Real-World Single-Center Experience with Neoadjuvant Gemcitabine, Cisplatin, and Durvalumab in Borderline Resectable #Cholangiocarcinoma Yawen Dong Vanja Podrascanin, MD rdcu.be/eLxXd Camille Stewart, MD Syed A. Ahmad